Breast Care

Papers
(The TQCC of Breast Care is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-01-01 to 2025-01-01.)
ArticleCitations
Which Patients Need Chemotherapy? From Pathological Risk Factors to Gene Signatures and Evaluation of Endocrine Response88
Palbociclib: Neue 5-Jahres-OS-Daten aus RCT bei HR+/HER2– aBC50
Evaluating HEmopatch® in Reducing Seroma-Related Complications following Axillary Lymph Node DIssection: A Pilot Study (HEIDI)46
Metaplastic Breast Cancer: Mesenchymal Subtype Has Worse Survival Outcomes21
First Experiences with Alpelisib in Clinical Routine: Case Reports from a German Breast Center19
PharmaNews18
Expert Discussion: Highlights from ABC6: Bridging the Gap and Insights in This First Virtual ABC Conference and from 10 Years ABC Consensus18
Associated Factors with Breast Nurses Unplanned Interventions in Patients Treated for an Early Breast Cancer16
Erratum16
ABC7 Consensus: Assessment by a German Group of Experts16
Kombinationstherapie bei HER2+ mBC16
Front & Back Matter15
Junge Patientinnen mit frühem HER2-positivem Brustkrebs14
A Response and Discussion with Respect to Gulcelik’s Study in Oncoplastic Level II Surgical Techniques for Breast Cancer Treatment13
Impact of Diabetes on Patient Outcomes in Breast Cancer Patients12
Treatment of Ductal Carcinoma in situ: A Register-Based Study of Norwegian Women Diagnosed between 1995 and 201811
Prepubertal Idiopathic Unilateral Gynecomastia: Case Report and Literature Review11
Insights from ASCO 202310
Menopausal Hormone Therapy and the Breast: A Review of Clinical Studies9
PharmaNews8
Adherence to Newly Implemented Tamoxifen Therapy for Breast Cancer Patients in Rural Western Ethiopia7
Invasive Lobular Carcinoma Has Worse Outcome Compared with Invasive Ductal Carcinoma in Stage IV Breast Cancer with Bone-Only Metastasis7
Biomarkers: Which Ones Do We Really Need Today?7
Clinicopathologic Features and Pathogens of Granulomatous Lobular Mastitis7
Concerning de Oliveira-Junior et al. “Oncoplastic Surgery in Breast-Conserving Treatment: Patient Profile and Impact on Quality of Life.” Breast Care. 2021;16(3):243–2537
Prevalence of Pathogenic Germline Variants in Women with Non-Familial Unilateral Triple-Negative Breast Cancer7
Objective Response to First-Line Treatment as a Predictor of Overall Survival in Metastatic Breast Cancer: A Retrospective Analysis from Two Centers over a 25-Year Period7
First-Line Efficacy of Anti-HER2 Treatments in Previously Treated HER2-Positive Metastatic Breast Cancer Patients: A Retrospective Observational Study Investigating the Efficacy of Re-Exposure to Anti7
Is 9-G DBT-Guided Vacuum-Assisted Breast Biopsy Sufficient to Completely Remove T1 Breast Cancers (below 20 mm)? Analysis of 146 Patients with Histology as Reference Standard7
Risk Factors for Idiopathic Granulomatous Mastitis Recurrence after Patient-Tailored Treatment: Do We Need an Escalating Treatment Algorithm?7
Long-Term Results of the TARGIT-A Trial: More Questions than Answers6
Translating Evidence into Practice: A Review of Clinical Practice and Outcomes following the Adoption of an Early Post-Mastectomy Discharge Protocol in a Nigerian Hospital6
The Role of High Intensity Focused Ultrasound in the Treatment of Fibroadenomas: A Systematic Review6
Contents Vol. 19, 20246
Immunotherapy in HER2-Positive Breast Cancer: A Systematic Review5
Effectiveness of Peer Support on Quality of Life and Anxiety in Breast Cancer Patients: A Systematic Review and Meta-Analysis5
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 20235
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 20235
PharmaNews5
Retrospective Impact of COVID-19 Pandemic on Primary Breast Cancer Care5
Vitamin D and Breast Cancer Risk: Evaluating the Association and Effective Risk Reduction4
Front & Back Matter4
Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients with Positive Nodes Using Low-Cost Dual Dye Technique: Identifying Factors Associated with Adequate False Negative R4
The Predictive Importance of Body Mass Index on Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer4
PharmaNews4
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 20224
Non-Surgical Site Pain in Women following Breast Cancer Surgery: A Systematic Review and Meta-Analysis4
Predicting Survival of Patients with Nonmetastatic Breast Cancer Based on Fibrinogen-to-Albumin Ratio and Lymphocyte-to-Monocyte Ratio: A Nomogram-Based Assessment4
Front & Back Matter4
Expert Discussion: ESMO 20244
Management of Idiopathic Granulomatous Mastitis: A Single Institution Experience4
PharmaNews3
How Can Oncoplastic Breast Surgery Contribute to the Management of Locally Advanced Breast Cancer in Sub-Saharan Africa?3
Prophylaxis of Neutropenia with Lipegfilgrastim in Breast Cancer Patients with Dose-Dense Chemotherapy: Results of a Noninterventional Study on Therapeutic Routine in Germany (NADENS)3
Treatments for Periductal Mastitis: Systematic Review and Meta-Analysis3
Treatment Outcomes according to the EndoPredict Score in ER-Positive, HER2-Negative Early Breast Cancer3
News from the San Antonio Breast Cancer Symposium 20223
Front & Back Matter3
Expert Discussion: SABCS 20213
Transferring MINDACT to Daily Routine: Implementation of the 70-Gene Signature in Luminal Early Breast Cancer – Results from a Prospective Registry of the Austrian Group Medical Tumor Therapy (AGMT)3
Adjuvant Treatment of Elderly Breast Cancer Patients: Offer the Best Chances of Cure3
Does Routine Follow-Up after Patients Have Completed Adjuvant Therapy for Early-Stage Breast Cancer at a Cancer Center Improve Prognosis?3
First-in-Class-Therapie mit Sacituzumab Govitecan3
Higher CD1a Levels Correlate with PD-L1 Expression and Predict Worse Overall Survival in Triple-Negative Breast Carcinoma3
PharmaNews3
Acknowledgement to Reviewers2
Quality Analysis of YouTube Videos Presenting Shoulder Exercises after Breast Cancer Surgery2
Clinical Axillary Staging in Breast Cancer Patients Using Ultrasound Imaging2
Front & Back Matter2
Acknowledgement to Reviewers2
Management of Patients with Breast Biopsy under Anti-Coagulation or Anti-Platelet Therapy: Results of a Survey of German Experts2
The Impact of Breast Awareness on the Early Detection of Breast Cancer in Young Women: A Systematic Review2
Moderate Intensity Exercise Reduces Side Effects of Cancer Therapy and Maintains Cardiorespiratory Fitness in Male Breast Cancer Patients: Findings from the BRECA Male Crossover Study2
Expert Discussion: HER2-Positive Breast Cancer2
Front & Back Matter2
Society Bulletins2
Innovative Standards in Surgery of the Breast after Neoadjuvant Systemic Therapy2
HER2-Low Breast Cancer: Where Are We?2
Front & Back Matter2
PharmaNews2
Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Case Report about a Male Patient with Pectoral Implants2
Lack of Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in Early Breast Cancer2
Expert Discussion: ASCO 20212
Keeping a Breast with Social Media: “Le Marteau Sans Maître?”2
PharmaNews2
A de Novo BRCA1 Pathogenic Variant in a 29-Year-Old Woman with Triple-Negative Breast Cancer2
Biologically Based Complementary and Alternative Medicine Use in Breast Cancer Patients and Possible Drug-Drug Interactions2
Front & Back Matter2
Treatment of Luminal Metastatic Breast Cancer beyond CDK4/6 Inhibition: Is There a Standard of Care in Clinical Practice?2
Treatment Options for Early Stage Inoperable Breast Cancer: Cryoablation or Radiotherapy?2
Prediction of Cardiac Toxicity by Measurement of Coronary Artery Calcium Scoring Method Using Chest Computed Tomography in Early Breast Cancer Patients Treated with Trastuzumab2
Locoregional Therapy: From Mastectomy to Reconstruction, Targeted Surgery, and Ultra-Hypofractionated Radiotherapy2
PharmaNews2
Malignancy Rate and Malignancy Risk Assessment in Different Lesions of Uncertain Malignant Potential in the Breast (B3 Lesions): An Analysis of 192 Cases from a Single Institution2
Front & Back Matter2
0.082226037979126